Home / Private raises / BIOVIE INC.
BIOVIE INC.
Biotechnology · Carson City, Nevada · $0 sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | D (new) | $0 | $0 | 1 | 506(b) | Options/warrants, Security to be acquired | Nov 3 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Issuer
| Industry | Biotechnology |
| Located | Carson City, Nevada |
| Entity | Corporation |
| Incorporated | Nevada |
| SEC CIK | 1580149 |
People named in the latest filing
| Name | Role |
|---|---|
| Cuong Do | President and CEO |
| Joanne Wendy Kim | CFO |
| Sigmund Rogich | Director |
| Michael Sherman | Director |
| Kameel Farag | Director |
| Amy Chappell | Director |
| Jim Lang | Director |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
